Sleep disturbances and suicidality: a common association to look for in clinical practise and preventive care by Christine Norra et al.
REVIEW ARTICLE
Sleep disturbances and suicidality: a common association
to look for in clinical practise and preventive care
Christine Norra & Nadja Richter & Georg Juckel
Received: 18 May 2011 /Accepted: 1 July 2011 /Published online: 23 July 2011
# European Association for Predictive, Preventive and Personalised Medicine 2011
Abstract Suicidality and suicide has been associated with
many risk factors, while recent clinical and epidemiological
studies increasingly point to a potential link between sleep
loss or sleep disturbances and suicidality. This review on
studies of sleep disturbances associated with suicidality, i.e.,
suicidal ideation, suicide attempt and completed suicide
suggests a frequent association especially with insomnia
and nightmares but also hypersomnia and sleep panic
attacks. In suicidal insomniacs with comorbid psychiatric
disorders, there is some evidence for an even independent
predictive nature of sleep problems for suicidality. Consid-
erations on the shared neurobiology, risk assessment and
treatment options complement the overview. Thus, sleep
disturbances may qualify as an individual treatable target of
personalised medicine in the clinical routine as well as in
suicide prevention programmes. A more detailed assess-
ment of sleep problems and identification of specific risk
domains in primary or secondary prevention of suicidality
seem to be a future area of high importance.
Keywords Sleep disturbances . Nightmares . Suicidality .
Personalised risk assessment . Suicide prevention .Mental
disorders
Introduction
Suicide is a complex health problem and a worldwide
leading cause of death with high annual mortality rates, e.g.
approximately 30,000 persons in the United States in 2010
[1] or 10,000 persons in Germany in 2009 [2]. Multiple
neurobiological, medical and psychosocial variables of
influence on developing suicidal tendencies are being
discussed [3–7] while it has been estimated that up to
90% of suicide completers have previously suffered from a
psychiatric disorder [8].
On the other hand sleep disturbances are very common
and have a major impact on physical and mental health, and
they are part of many psychiatric disorders [9, 10]. A close
association between suicidality and sleep disturbances
especially insomnia has been discussed for a while with
recently increasing concerns [6, 11–14], but only few
studies indeed focused on the potential predictive quality
of sleep disturbances or sleep loss for suicidal ideation and
behaviours (e.g., [15–17]). Assessment and treatment of
individual sleep disturbances might represent a personalised
preventive measure of suicidality and suicide. This article
aims at giving an overview of the current topics of research
in this area.
Suicidality and sleep disorders
Sleep loss and Insomnia
Insomnia is the most common sleep problem with about
one third of the general population suffering [10] but only a
small number of epidemiological studies investigated
suicidality and insomnia complaints by assessing subjective
sleep variables (Table 1).
Detailed reports of sleep problems (difficulty initiating
sleep, maintaining sleep, early morning awaking, and
insomnia) were identified to be significantly associated
with an increased risk of suicidality, i.e. suicidal ideation,
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plans or attempts (unadjusted odds ratio´s, OR’s=4.2–9.09)
in the preceding 12 months in a representative adult sample
using data from an American representative survey
(National Comorbidity Survey Replication) [16]. This
relationship remained stable in most cases after controlling
for diagnoses of depression, anxiety disorder and sub-
stance abuse. Remarkably, difficulty in initiating sleep
predicted suicidal ideation and planning, problems in
maintaining sleep predicted suicidal ideation and suicidal
attempt, and early morning awaking and insomnia scores
were predictive for all three suicidal dimensions (suicide
ideation, planning and attempt) (OR’s=1.2–3.0) [16].
These results on abnormalities in multiple subjective sleep
variables are complemented by the Danish follow-up GAZEL
study between 1990 and 2009 that showed completed suicide
was almost fivefold enhanced in men who reported of three
types or more of sleep disturbances [18].
Adult data from the “Korean National Health and
Nutrition Examination Survey” showed an association
between decrease in sleep time and increase in suicidal
ideation in women [19]. Analysis of another representative
adults sample in the United States (National Comorbidity
Survey) gave evidence that short sleep was associated with
2.5 to 3fold increase in suicidal ideation and suicide attempt
[15]. However, the effect on suicidal attempt was predom-
inantly explained by panic attacks, mood and substance use
disorders. Liu et al. showed that sleep duration below 8 h
was associated with an increase in risk of suicide attempts
in Chinese community adolescents [20]. Notably, as in
adolescents the sleep duration and its association with
suicidal attempts and various other risky behaviours will
probably have to be evaluated somewhat differently [21]
the body of this particular literature will not be discussed in
this overview. However, in a very recent study addressing
this issue [22] short sleep≤5 h was found to be a marker of
severity of suicidal behaviour among female suicide
attempters but not male in comparison to other psychiatric
patients without any suicide attempts and healthy controls.
Thus, some authors assume sleep duration to be a relatively
simple way for screening of sleep loss as a potential marker
of individuals at risk of suicidality [6].
Suicide risk assessment plays a key role in clinical
practise but associated clinical studies on sleep problems
are still rare albeit findings are in line with the outcome in
epidemiological investigations. Hall et al. [23] examined
emergency patients after serious suicide attempts. A
detailed review of symptoms and common suicide risk
factors revealed that the presence or absence of suicidal
ideation or a specific plan did not define patients at risk for
serious suicide attempts while rather the presence of
insomnia but also of severe anxiety and/or panic attacks,
depressed mood, recent loss of close personal relationship,
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helplessness and worthlessness was most predictive.
Importantly 46% of the patients reported global insomnia,
92% of the patients reported partial insomnia, i.e., difficulty
falling asleep, sleep continuity disorder and early morning
awaking. As only 14% of suicide attempters had suicidal
thoughts with any previous plan prior to the suicide attempt
that was potentially of impulsive or reactive nature,
insomnia in this study was more frequently found prior to
severe and near-lethal suicide attempts than specific suicide
plans [23]. Sjöström et al. [24] found similar rates with
89% of patients admitted after suicide attempts to report on
sleep disturbances with main complaints of difficulties
initiating sleep (73%), difficulties maintaining sleep (69%),
nightmares (66%) and early morning awakening (58%).
Another recent large-scale clinical study among psychi-
atric outpatients in China using a detailed sleep question-
naire strengthened the evidence of an association between
insomnia and suicidality [17]. Frequent insomnia was
independently associated with enhanced incidence of
suicidal attempts (OR=6.96) as well as lifetime prevalence
of suicide attempts (OR=1.55) [17]. Focusing on patients
presenting at a community based private sleep medical
centre Krakow et al. [25] demonstrated that suicidality was
indeed common, too. Overall 13.3% of patients reported
suicidal ideation showing significant associations between
greater frequency of severity of sleep problems and
insomnia, but also nightmares and other parasomnias and
mostly independent of depression severity. Importantly,
suicidal ideation was evaluated as clinically significant in
4.5% of patients [25].
Nightmares
There is body of literature on nightmares and suicidality
strongly pointing to its link [13, 24, 26, 27]. In a large and
prospective Finish population-based follow-up study the
frequency of nightmares was directly related to the risk of
suicide [27]. The adjusted relative risk of suicide was 57%
higher in subjects with occasional nightmares and 105%
higher in frequent nightmares as compared to subjects
without any nightmare experiences [27].
One outpatient study [24] found nightmares in 66% of
medical and psychiatric patients and nightmares were
associated with a 5-fold increase in risk for high
suicidality. This relationship remained stable after adjust-
ment for psychiatric diagnosis and psychiatric symptom
intensity. In the 2-month follow-up of patients after a
first suicide attempt and admission to hospital frequent
nightmares predicted a repeated attempt (OR=3.15) (but
neither difficulties initiating/maintaining sleep nor early
morning awaking) with a further heightened risk (OR=5.20)
when nightmares were also reported at follow-up [26]. In the
study of Li et al. [17] recurrent nightmares were significantly
and independently associated with an increased incidence of
suicide attempts 1 year after questionnaire assessment in
psychiatric outpatients. Another clinical outpatient study
investigated frequency and severity of symptoms of
nightmares, suicidality and depression [13]. Insomnia
and nightmares were significantly associated with depressive
and suicidal symptoms, but after controlling for additional
variables, e.g., depression and sex, only nightmares remained
associated with suicidal ideation, and this effect in trend was a
little stronger in women [13].
On the other hand, patients with major depression, who
reported frequent and frightening nightmares, showed
higher suicidality than those without any nightmares
(particularly women) [28]. Higher rates of nightmares and
insomnia were also found in melancholic depression with
suicide attempts as opposed to melancholic non-attempters,
but there were no differences in non-melancholic depressed
patients without or without attempts [29]. The authors
conclude that melancholic features like feeling worse in the
morning might be associated to enhanced risk of suicidality
via a more negative affect and dream content though this
hypothesis remains subject to further studies.
In addition, psychotropic medication was independently
associated with recurrent nightmares, i.e., antidepressants,
particularly selective serotonin reuptake inhibitors (SSRI),
serotonin-norepinephrine reuptake inhibitors (SRNI), hetero-
cyclics, and non-benzodiazepine hypnotics were independently
associated with recurrent nightmares after adjustment for
confounding variables [17].
Others parasomnias
Misinterpretation of suicidal behaviour (“pseudo-suicide”)
in patients with parasomnias has been discussed especially
in the forensic context due to injuries or violent behaviours
but these are to be diagnosed as sleep-related complex
behaviours like sleep walking or others and therefore are
regarded to be without premeditation, conscious awareness,
or individual responsibility [30]. However, idiopathic REM
sleep behaviour disorder (RBD) may also lead to conflicts
with the bed partner and subsequent suicidality to be
resolved by drug treatment of the RBD [31].
Hypersomnia
As daytime sleepiness or fatigue might also be a symptom
of depression a careful investigation of hypersomnia in
depressed patients is always advised too. However, a
Brazilian cross-sectional sample of psychiatric outpatients
was the first to describe a strong relationship between
excessive daytime sleepiness (EDS) and symptoms of
depression as well as suicidal ideation [32]. With regard
to obstructive sleep apnoae the presence of symptoms of
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sleep-related breathing disorder (SRBD) was associated
with depressive symptoms [13, 33], but in the outpatient
study of Bernert et al. [13] there was no association of
SRBD with symptoms of suicidality. Nevertheless, women
who were assigned to a posttraumatic stress disorder
(PTSD) programme revealed higher scores for depression
and suicidal ideation if they also experienced a SRBD [34].
Moreover, there is the interesting case of a 74-year-old male
outpatient, who presented not only with depressive mood and
severe suicidal ideation including active suicide plans, but also
further confirmed severe EDS and heavy disruptive snoring
[35]. Although the patient declined psychiatric hospitalisation
and any antidepressant medication he agreed to a combined
polygraphic sleep study corresponding to a severe sleep
apnoae. After self-titration nCPAP treatment not only his
sleep quality improved but there were no symptoms of
depression and suicidal ideation two weeks later either and
he stayed in remission until follow-up for three months [35].
Thus, depression with suicidal ideation may also occur as a
symptom of untreated SAS in a medical emergency situation.
Further sleep disorders
Of note, there are no studies on suicidality in narcolepsy;
however, one has to be aware that the occasional odd
behaviour might be mistaken as suicidal action [36].
Another highly prevalent sleep disorder, the restless legs
syndrome (RLS) is frequently comorbid with depressive
syndromes possibly due to a monaminergic deficit (e.g.,
[37, 38]). Here, whether the RLS disorder itself or the
treatment with dopaminergic drugs that are known to
enhance impulsivity may also lead to subsequent suicidality
is a matter of current debate [39].
Sleep disturbances in psychiatric disorders
associated with suicidality
Patients with major depression are at highest suicide risk
followed by patients addicted to alcohol and patients with
schizophrenia [5]. At the same time sleep disturbances are
frequent in patients with psychiatric disorders [9, 40, 41], e.
g., about 75% of psychiatric inpatients were found to suffer
from sleep disorders [40]. Sleep disturbances with com-
plaints of insomnia or hypersomnia lead to a 2.5 fold rise in
mental disorders [9]. Moreover, persistent insomnia is
associated with much higher incidences of major depression
(OR=39.8, 95%, CI=19.8–80.0) [42], but also some
increase in anxiety disorder and substance dependence
[42]. Deaths due to suicide were seen 7-fold enhanced over
a one year period in patients with sleep disorders as
opposed to age- and sex-matched controls but this effect
concerned mainly patients with associated psychiatric
diagnoses [41]. In a community-based prospective study
(N=14,456 including 21 completed suicides) over a 10-year
period, poor sleep quality and depressive symptoms were
among the factors that predicted late-life suicide [43].
Depression
Sleep disturbances and especially insomnia are a core
symptom of depression [44, 45] and double the risk of
developing a depression [46]. Although both entities share a
common neurobiology like alterations in neurotransmission
and genetic polymorphisms, hypothalamo-pituitary-adrenal
(HPA) overactivity, or impaired neuronal plasticity [47] that
are also important for suicidality (see below) only few
studies in fact focused on analysing the relationship between
these variables supporting the hypothesis that comorbid
depression and sleep disturbances is related to suicidality.
Agargun et al. [48] demonstrated that poor subjective
sleep quality as measured with the Pittsburgh Sleep Quality
Inventory (PSQI) was associated with suicidal behaviour in
major depression. Suicidal depressive patients reported
significantly higher scores of subjective sleep quality, sleep
latency, sleep duration, habitual sleep efficiency and PSQI
global scores than non-suicidal patients. He also found
higher rates of middle and terminal insomnia in suicide
attempters with melancholic depression. In the group of
non-melancholic depressed patients there was no such
finding [29]. Besides, not only depressed patients with
insomnia but also those with hypersomnia were significantly
more likely to become suicidal than depressive patients
without sleep disturbances [49]. However, in another
outpatient study higher scores of suicidality were found in
depressed patients with insomnia than in depressives with
excessive sleepiness [50].
McCall et al. [51] identified insomnia as an indicator of
suicidal ideation (suicide item taken from the Hamilton
rating scale of depression, HRDS) during a clinical
medication trial of SSRI and hypnotics (fluoxetine
±eszopiclone) in comorbid depression and insomnia. The
strong impact of insomnia is underlined as insomnia
severity remained an independent factor of suicidal ideation
even in the combination with the severity either of
anhedonia or depressed mood [51]. Otherwise, patients
who received treatment for their insomnia showed a
decrease in their depressive symptoms [52] pointing to its
potential secondary nature like Taylor [14] already commented
that in some cases insomnia may be instigating, perpetuating
or exacerbating depression.
Bipolar disorder
Sleep disturbances in patients with bipolar disorder are
coming more into focus as impaired sleep may also be a
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predictor of manic episodes and residual insomnia or
hypersomnia in the euthymic period may facilitate a bipolar
relapse [53, 54]. Eidelmann et al. [55] found a positive
correlation between the variability in falling asleep time and
concurrent depressive symptoms while sleep efficiency
positively correlated with concurrent manic symptoms.
An association of psychomotor agitation and other non-
euphoric hypomania symptoms with insomnia was
observed in patients retrospectively classified as major
depressive disorder (N=314), and the agitated subsample
also showed higher levels of suicidal ideation [56].
Summarising preliminary findings of sleep disturbances
and suicidality in bipolar patients may point to some
association, too. Whether sleep items included in charts of
lifetime rhythmicity of manic depressive features might be
identified as a potential marker for bipolar patients at risk
for suicide [57] is another interesting approach for future
research.
Schizophrenia
Sleep disorders are also common in patients with schizo-
phrenia most notably insomnia with deficit in initiating and
maintaining sleep [58] corresponding to polysomnographic
findings of prolonged sleep-onset latency, a decrease in
sleep efficiency and changes in REM- and NonREM sleep.
Interestingly, enhanced REM-activity (rapid-eye-movement)
and -time was found to be associated with suicidal behaviour
in psychotic patients with schizophrenia or schizoaffective
disorder while the difference against non-suicidal patients
became less significant after excluding the schizoaffective
suicidal patient group [59]. In line with these findings REM
sleep time was increased in schizophrenia patients with
suicidal ideation and attempts as opposed to non-suicidal
schizophrenics [60]. Here, more detailed replication studies
are needed to examine the potential independence of
psychiatric diagnosis with regard to EEG abnormalities in
suicidal behaviour. Of note, one would also have to take into
account possible side effects of antipsychotics that may affect
the sleep-wake rhythms negatively or even provoke para-
somnias and accidental suicides [61].
Panic disorder and PTSD
Patients with panic disorder often complain about sleep
disorders, especially sleep panic [62]. Some authors propose
the highly frequent nocturnal panic attacks as a more
severe variation of panic disorder [63]. The co-occurrence
of panic disorder with major depression is extremely high
[11, 62, 64, 66] and a vast majority of comorbid patients
also experience insomnia [65, 66]. It is assumed that this
comorbidity seems to be a potential modifier in develop-
ing suicidality. In an early study Fawcett et al. identified
panic attacks and global insomnia among nine clinical
features that were associated with suicide within 1 year in
psychiatric patients with major affective disorders (N=
954) [64]. Moreover, recurrent sleep panickers showed an
association with suicidal tendencies [66]. However, sleep
panic alone was not found to be a risk factor for suicidality
but it seems to be a decisive modifier towards a more
severe panic disorder [62].
Among PTSD sufferers insomnia and nightmares are the
most commonly reported subjective sleep disturbances [34,
67]. They even reported more weeks per year with sleep
difficulties than subjects with other psychiatric disorders
(adult separation anxiety, alcohol dependence, and major
depression) [67]. Krakow et al. analysed sleep in female
sexual assault survivors with PTSD and additional regis-
tering of sleep SRBD and sleep movement disorders. The
women with both types of sleep disorder suffered from
greater depression and suicidality [34].
Impulsivity, aggression, and substance abuse
Evidence for an association of personality features like
impulsivity and aggression to sleep disturbances comorbid
with suicidality is sparse and calls for expansion of
studies. In patients with borderline personality disorder
(BPD) difficulties in sleeping were seen to be associated
with a higher risk of suicide attempts [57]. Some
evidence also comes from a study of insomnia in male
prisoners (N=1,462), where insomnia was significantly
related to actual suicidality as well as lifetime history of
suicide attempts. Still, several confounders like axis 1
psychiatric disorder, childhood trauma, neuroticism, low
resilience, and anger were significantly associated with
insomnia [68].
Alcoholism is also associated with an increased risk of
impulsivity and suicidal behaviour [69]. In alcoholic
patients either with or without secondary depression
increased REM density at admission and decreased total
sleep time at about 2–4 weeks of abstinence predicted
relapse three months later [70]. Sleep disturbance in
alcoholic patients might therefore be a sign of worse
outcome of illness and go along with a higher risk for
suicidality.
Aetiological links of sleep disturbances und suicidality
Serotonin
Among the neurotransmitters serotonin is considered to be a
major candidate for an aetiological link between sleep
disturbances and suicidality [11]. Serotonin promotes waking
states and the initiation of sleep with successive inhibition of
300 EPMA Journal (2011) 2:295–307
slow wave sleep (SWS) and rapid-eye-movement (REM)
sleep. Serotonergic neurons of the dorsal raphe nucleus
steadily fire during waking but their release of serotonin
declines during SWS and reaches its nadir during REM sleep
[71]. Administration of several selective serotonergic recep-
tor antagonists in rodents as well as in humans including
those with chronic insomnia and mood disorders led to an
increase of SWS and a reduction of REM sleep [72].
Contrariwise insomnia is related to reduced serotonergic
function, e.g., sleep restriction for 4 h over 8 days led to a
desensitisation of 5HT1A receptor system in rats [73].
In depression, SWS was correlated to serotonin metab-
olite (5-HIAA) in the cerebrospinal fluid, e.g. in depression
[74]. SSRI treatment in depression resulted in REM
suppression and impairment of sleep efficiency [75, 76],
and the disruption of antidepressive treatments (SSRI,
TCA) was followed by a fivefold increase in suicidal
behaviours [77]. In addition, impairment of serotonergic
activity was found after completed suicide in the brainstem
and in the cerebrospinal fluid of suicide attempters and in
individuals with high rates of violent aggression and
impulsivity [3, 78–80], as well as reduced serotonin
synthesis in the prefrontal cortex of suicide attempters
[81]. Moreover, in patients with the same psychiatric
diagnoses, the genotypes carrying the s allele of the
serotonin transporter gene promoter (5-HTTLPR) were
significantly more frequent in suicide attempters than in
non-attempters (p=.004) [82].
The findings of a “low serotonin syndrome” in violent
suicide attempts encouraged the hypothesis that serotonin is
responsible for the relationship between sleep disturbances
and suicide [11, 83–85]. Receiving not enough sleep is a
problem of modern society like in Japan where sleep
duration is the lowest in the world while suicidality is rising
[6]. Kohyama suggested that people with sleep disturbances
and a subsequent sleep debt are unlikely to perform
sufficient physical activity to activate serotonergic activity
to a desirable level [6]. While paradoxical sleep deprivation
might increase the activity of the serotonergic system, total
sleep debt is probably related to suicidality through reduced
serotonin levels. But it was also argued that sleep
deprivation is known to increase the activity of the
serotonergic system and mood in depressed patients [86]
though may not necessarily imply an association of sleep
loss and serotonin in suicidality [87].
Some other neurotransmitter or hormonal candidates
However, a possible relationship between sleep depth and
suicide cannot be decisively attributed to a single neuro-
transmitter system [84]. Recently a group of hypothalamic
peptides is coming to the fore. The orexins or hypocretins
are involved in the regulation of sleep, appetite and state of
arousal. Patients (N=101) who were enrolled shortly after
suicide attempt showed a significant negative correlation
between orexin in cerebrospinal fluid and global illness
[88]. One might hypothesise that reduced orexin levels
could therefore be involved in the aetiology of sleep
disturbances and suicidality.
With regard to the HPA axis a dysfunction of cortisol
secretion with increased levels in the evening nadir before
sleep onset has been related to suicidality and suicide
attempts in depression [89, 90]. Likewise a dysregulation of
the delta sleep-inducing peptide (DSIP) and its association
to cortisol secretion was suggested as candidate hormone in
patients with major depression with suicide attempts [91].
EEG sleep abnormalities
Further evidence for a neurobiological link between sleep
disturbances and suicidality is provided by polysomno-
graphic studies. EEG sleep characteristics in depressed
adults revealed an increase in REM sleep time (and phasic
activity in the second REM period but less delta counts in
the fourth Non-REM period) in the subgroup with a history
of suicide attempts [92]. Similar sleep profiles with
shortened REM latency and increase in REM percentage
in suicidal ideation and behaviour were replicated in
patients with depression or schizophrenic psychosis [59,
93]. In a study with depressed patients (N=26), who
underwent 3 nights of polysomnographic recordings
subjects with higher suicidal scores, had a significantly
shorter mean REM latency and a higher mean REM
percentage than the non-suicidal subjects [93]. However,
several EEG studies in depressed adolescents particularly
underline the findings of an increase in REM activity
[89]. Moreover, alterations of REM related negative
dream like contents and associations with suicidal
tendencies as suggested by Agargun et al. were inter-
preted as a failure to self-regulate mood and integrate
affect into long-term memory networks during sleep [93].
Overall, these EEG alterations findings seem to represent
an aggravation of sleep profiles in depression with loss of
sleep continuity and loss of SWS as well as disinhibition of
REM sleep with shortened REM latency and a high REM
density also linked to corticoid overdrive and low seroto-
nergic activity [47].
In general, there is a paucity of EEG studies that focus
on the potential link between severity of suicidal ideation
and behaviour to sleep profiles beyond of psychiatric
disorder. However, polysomnography of nightmares for
example show abrupt awakening usually from REM sleep
typically lasting for about 10 min in association with vivid
dreamlike features [94] on the one hand. Here, REM
suppressing serotonergic antidepressant agents with may be
of help. On the other hand, polysomnographic findings of
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difficulties of initiating sleep and/or maintaining sleep in
insomnia show a loss of SWS and REM going along with
an increase in sleep latency and awakenings and reduced
sleep efficiency [94]. Here, 5HT2 receptor antagonists may
improve SWS in these individuals. Similar serotonergic
agents that enhance serotonergic neurotransmission decrease
aggression, impulsivity, and suicidal behaviour [83], and the
underlying neurobiological link between the EEG abnormal-
ities in sleep disturbances and suicidality needs special focus
in particular studies.
Hypnotics
Hypnotics have been related to an increase in mortality in
the general population [12, 95]. In contrast, positive effects
of hypnotics on insomnia in depression have been
demonstrated (e.g. [96]) but no such study focused on
items of suicidal ideation as it was often postulated as an
exclusion criterion [97] or this piece of information was not
given [51].
Nonetheless, the use of sedatives-hypnotics (in particular
zolpidem and zaleplon) was a stronger predictor for suicidal
thoughts and attempts than insomnia in household respondents
(N=5,692) [98]. In the elderly (+65) population sedative
treatment even revealed a 14-fold increase of risk for late life
suicide, and after adjustment for psychiatric (DSM-IV)
disorders, only hypnotics but not antidepressants and
antipsychotics still represented an independent risk factor
for suicide [99]. Prescriptions of sedatives-hypnotics in the
preceding 12 months were associated with suicidal thoughts,
plans and attempts [98, 99], and a current prescription of
hypnotics still leads to a four-fold increase in suicide risk in
the elderly [99].
With regard to the use of antidepressants effective in
treatment of depression the unclear issue of SSRI facilitat-
ing suicide has been analysed. There may be an associated
protective factor of suicide attempt in adults and elderly
with depression while the risk of suicide attempt may be
increased among adolescents [100]. High dose-stimulant
therapy in narcolepsy or idiopathic hypersomnia was not
found to be related to suicide-related behaviours [101].
Circadian rhythms
The influence of biological and social “zeitgebers” is
reflected in the diurnal variability of suicide attempts and
deliberate self-injuries with a peak in the evening but
completed suicides in the early morning (see overview in
[83]). In line are findings in adolescents who were 24%
more likely to suffer from depression (OR=1.24) and 20%
more likely to have suicidal ideation (OR=1.20) with
parentally set bedtimes of midnight or later than with early
set bedtimes [102].
Chronobiology divides individuals into two chronotypes
with morning types initiating their activities in the first
hours of the day whereas evening types start later in the day
with a larger variability in bed and rising times. Recent
findings suggest that the development of major depression
and sleep disorders is linked to a patients’ biological
chronotype. While circadian morningness type may be a
significant relief factor in depression the eveningness type
has been linked with impulsivity and may represent a risk
factor for suicidality, most notably of violent suicide
attempts [103]. Here, the role of melatonin to circadian
rhythms, sleep disturbances and suicidality remains open to
research [104] as well as the role of a variety of potential
circadian genes [105].
Shift work like other potential conditions leading to
disruption of circadian rhythms might result in disruption
of different psychological and physiological processes.
An association of shift work and suicidal ideation was
shown in policewomen with higher depressive symptoms
and increase in day shift time hours, and among their
male colleagues with higher PTSD symptoms with
increasing afternoon hours [106]. Thus, interventions in
shift work and jet lag should always be considered in
patients with recurrent mood disorders, or at risk for
suicide [107].
Psychological factors
Sociodemographic risk factors, e.g., education, financial
income, employment, marital status, conflicts in partnership
have a strong impact on suicidality [4, 7, 108], and here
poor sleep may act as an additional stressor. However, the
link of social stressors like work-related stress or unem-
ployment and altered diurnal rhythms to comorbidity of
sleep disturbances and suicide attempts or completed
suicides remains an open question and a high number of
unreported cases have to be assumed. Apart from the
psychological variables impulsivity or aggression that are
closely linked to the interplay between serotonin dysfunc-
tion and suicidality [78, 79], hopelessness belongs to the
main psychological constructs that may act as moderators
of suicidality [109]. Similarly, hopelessness has also been
identified as a dysfunctional cognition that maintains
maladaptive beliefs in sleep in chronic insomniacs [110]
as well as in depressed insomniacs [111]. Hence, hope-
lessness in ever overcoming sleep problems would be one
item of interest in sleep oriented assessment of suicidal
tendencies. In fact, Fawcett et al. [64] noted hopelessness
as one of nine features in depressed patients that was
associated with suicide within one year. However, to
further speculate about the role of potential psychosocial
factors known to contribute to sleep disturbances—either
comorbid with psychiatric disorders or not—resulting in
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suicidality would be out of the scope of this overview and
these complex associations have not particularly been
focused in studies so far.
Limitations
Current research lack studies with profound methodological
designs addressing the particular issue on sleep loss or
disturbances and suicidality including neurobiological
markers. Most studies rely on subjective estimations on
sleep and sleep variables only and there are hardly any
objective measurements or only small polysomnographic
recording EEG studies to verify sleep loss or sleep
disorders in suicidality. Several prospective studies concen-
trating on the target syndromes like insomnia or nightmares
have been linked to suicidality but were either non-clinical
or cross-sectional and are not based on diagnostic inter-
views or examinations. Apart from Krakow et al. [34] there
is a paucity of formal polysomnographic sleep studies
resulting in diagnoses on sleep disorders and suicidality. On
the other hand, results of clinical studies focusing on this
link cannot be compared to sleep problems in the general
population. Then, sometimes suicide items were taken
from established investigator-rated questionnaires, e.g.,
for assessment of depression but were not primarily address-
ing different items of suicidality.
Moreover, the suggested bidirectional link between sleep
disturbances or polysomnographic sleep abnormalities and
suicidality on the basis of psychiatric disorders as a
common pathway [11] cannot be entirely supported, as
sleep disturbances frequently predicted suicidality indepen-
dent of psychiatric diagnoses [5, 13, 17, 24, 25, 51]. In
addition, a large number of confounders complicate the
interpretation of findings. Among them and yet not properly
identified are various chronic medical conditions related to
insomnia that may also be a factor as risk for successive
insomnia [112] as well as for suicidality [113].
Preventing suicide by risk assessment and treatment
of sleep disturbances [Fig. 1]
Personalised medicine applies particularly to the field to
suicidality and individual patients’ needs. As opposed to
managed care protocols physicians have to identify indi-
vidual risk factors and treatment strategies decisions, and
higher awareness of the potential link between sleep
problems and suicidality is needed. Individuals, who suffer
from sleep disturbances that may be a symptom of
psychiatric distress or suicidality, do not frequently search
for formal mental health treatment [16]. However, sleep
disturbances represent a “modifiable” risk factor [64] of
suicidality giving it a unique position among other risk
factors. Sleep medicine interventions may be an option in
secondary preventive programmes after suicide attempts or
even qualify as a tool of primary prevention.
Identification of vulnerable individuals at high risk calls
for a careful assessment of sleep and sleeping habits. Here,
an individualised assessment is essential to identifying
relevant risk factors. This assessment of individual sleep
history and complains would also have to be included in the
assessment of suicide risk factors (e.g., sociodemographic
risk factors, current stressors, previous history of suicide
attempts, substance abuse, family history). Further simple
measures like psychometric instruments for sleep complains
and sleep quality as well as sleep diaries may be included in
the individual diagnostic procedure as well as advanced
technology in sleep medicine diagnostics like ambulatory
polysomnography. Differential diagnosis including organic
diagnosis and disease specific treatments of sleep apnoae or
restless legs seems mandatory.
Instructions in sleep hygiene are to be given as a basic
principle for example lengthening sleep duration or
setting regular bedtimes that could be protective against
depression and suicidal ideation [84, 101]. The presence
of insomnia or nightmares comorbid with depression will
probably always demand an assessment of suicide risk and
further actions while specific sleep medicine inventions
like drug treatment are available for disorders like
insomnia and nightmares suspected to enhance suicidal
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Fig. 1 Assessment and treatment of sleep disturbances in suicide
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tendencies. In the hypnotic treatment one would have to
take care of potential side effects with enhanced suicidality
or consider non-pharmacologic strategies. One might also
consider psychotherapy including cognitive behaviour
therapy (CBT), interpersonal therapy (IPT) or dialectic
behavioural therapy (DBT) to reduce suicidal tendencies
in the context of depression, aggression or impulsivity.
Moreover, therapeutic efforts in stabilising social rhythms
[114] in mania, depression or beyond may not only
promote stable sleep patterns and reduction of sleep
disturbances but also prevent suicidal tendencies in a high
risk patient population.
Potential impact of regular exercise on sleep
behaviour and suicidality
Regular exercise appears to substantially improve sleep
quality especially in less active individuals with sleep
complaints as well as in patients with chronic insomnia
[115–118]. On the other hand, the beneficial effect of
exercise on mental health and psychic disorder especially
depression is well established (e.g., [119, 120]). Physical
activity is not only known for a strong protective
association with depressive syndromes [121, 122] but also
to reduce rates of rates of suicidal ideation [121], suicide
attempts [122, 123] and completed suicides [124]. Potential
mediators for the positive impact of regular exercise on
sleep behaviour and suicidality possibly include affective,
functional, and metabolic mediators specific to sleep
architecture parameters [118] along with increase in self-
esteem and perceived social support during sport participa-
tion [122]. Thus, regular and moderate physical activity
should belong to the recommendations in individuals with
sleep disturbances, who might also be at risk of low mood
and suicidality.
Conclusion and outlook
Currently the available epidemiological and clinical studies
strongly point to a link between sleep loss or sleep
disturbances and suicidality, i.e., suicide ideation, suicide
attempts or completed suicide. This seems to apply in
particular for insomnia and nightmares that should at least
be taken as a warning sign for precise assessment of
suicidality. Most sleep problems or defined sleep disorders
represent a treatable risk factor at comparatively low cost as
opposed to the more complex suicide prevention strategies
and programmes that are still not sufficiently effective.
Moreover, if sleep disturbances would in fact emerge as an
independent predictive risk factor for suicidal tendencies and
actions—as some of the studies suggest after adjustment for
confounding factors and illnesses (e.g., depression, PTSD,
alcohol)—Pigeon and Caine pose the question whether it is still
premature to include sleep interventions in suicide prevention
efforts or even imperative [85]. Kohyhama proposed that
public health initiatives encouraging a longer duration of sleep
may provide a simple way of prevention either in primary or
secondary prevention in a high risk population [84]. At this
stage prospective sleep studies and more objective measures
of sleep disturbances, neurobiological and circadian variables
are urgently warranted to enlighten the association of
suicidality either with or without psychiatric disorders, to
promote preventions and targeted therapies in reducing
suicidal tendencies in vulnerable individuals, and to define
the role of sleep medicine interventions in this area.
Assessment and treatment of individual sleep disturban-
ces might represent a personalised preventive measure of
suicidality and suicide behaviour and should therefore be
included in everyday routine clinical history as well as in be
especially targeted in primary and secondary suicide
prevention programmes.
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